30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States

Aegerion Pharmaceuticals Inc (AEGR)

Track

Stock chart
Ticker: AEGR
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Broadfin Healthcare Master Fund Ltd
1 purchase — total 131,250 USD
Buy 13 Sep 2016
Value US$4,047,288.40 | Price 195.39 | Shares 12,887
Buy 12 Sep 2016
Value US$2,336,245.75 | Price 32.58 | Shares 75,813
Buy 12 Sep 2016
Value US$1,559,524.28 | Price 475.32 | Shares 66,947
Buy 9 Sep 2016
Value US$159,500.00 | Price 1.60 | Shares 100,000
Buy 11 Nov 2015
Value US$383,600.00 | Price 10.96 | Shares 35,000
Buy 11 Nov 2015
Value US$56,049.00 | Price 10.99 | Shares 5,100
Buy 19 Aug 2014
Value US$35,236.00 | Price 30.64 | Shares 1,150
Buy 31 Jul 2014
Value US$79,051.00 | Price 34.37 | Shares 2,300
Buy 31 Jul 2014
Value US$257,488.00 | Price 33.44 | Shares 7,700
Buy 3 Jun 2014
Value US$301,200.00 | Price 30.12 | Shares 10,000
Buy 27 May 2014
Value US$315,900.00 | Price 31.59 | Shares 10,000
Buy 20 May 2014
Value US$305,300.00 | Price 30.53 | Shares 10,000
Buy 8 May 2014
Value US$1,835.08 | Price 35.29 | Shares 52
Buy 8 May 2014
Value US$66,874.84 | Price 34.33 | Shares 1,948
Buy 8 May 2014
Value US$66,400.00 | Price 33.20 | Shares 2,000
Buy 8 May 2014
Value US$1,059,300.00 | Price 35.31 | Shares 30,000
Planned sale 30 Apr 2014
Value US$51,406.90 | Price 43.90 | Shares 1,171
Planned sale 30 Apr 2014
Value US$46,591.22 | Price 43.18 | Shares 1,079
Planned sale 31 Mar 2014
Value US$4,720.00 | Price 47.20 | Shares 100
Planned sale 31 Mar 2014
Value US$46,556.51 | Price 46.51 | Shares 1,001
Planned sale 31 Mar 2014
Value US$52,670.16 | Price 45.84 | Shares 1,149
Planned sale 14 Mar 2014
Value US$41,584.00 | Price 51.98 | Shares 800
Planned sale 14 Mar 2014
Value US$46,179.00 | Price 51.31 | Shares 900
Planned sale 14 Mar 2014
Value US$14,907.00 | Price 49.69 | Shares 300
Planned sale 14 Feb 2014
Value US$32,260.00 | Price 64.52 | Shares 500
Planned sale 14 Feb 2014
Value US$94,710.00 | Price 63.14 | Shares 1,500
Planned sale 11 Feb 2014
Value US$150,750.00 | Price 67.00 | Shares 2,250
Planned sale 10 Feb 2014
Value US$31,439.34 | Price 64.69 | Shares 486
Planned sale 10 Feb 2014
Value US$57,348.00 | Price 63.72 | Shares 900
Planned sale 10 Feb 2014
Value US$177,113.16 | Price 62.94 | Shares 2,814
Planned sale 10 Feb 2014
Value US$203,643.00 | Price 61.71 | Shares 3,300
Planned sale 16 Jan 2014
Value US$5,951.00 | Price 59.51 | Shares 100
Planned sale 16 Jan 2014
Value US$111,317.96 | Price 58.59 | Shares 1,900
Planned sale 2 Jan 2014
Value US$42,847.02 | Price 71.41 | Shares 600
Planned sale 2 Jan 2014
Value US$28,087.00 | Price 70.22 | Shares 400
Planned sale 2 Jan 2014
Value US$96,414.44 | Price 71.42 | Shares 1,350
Planned sale 2 Jan 2014
Value US$63,584.01 | Price 70.65 | Shares 900
Planned sale 16 Dec 2013
Value US$13,476.00 | Price 67.38 | Shares 200
Planned sale 16 Dec 2013
Value US$119,210.58 | Price 66.23 | Shares 1,800
Planned sale 2 Dec 2013
Value US$49,769.02 | Price 71.10 | Shares 700
Planned sale 2 Dec 2013
Value US$108,653.76 | Price 70.10 | Shares 1,550
Planned sale 2 Dec 2013
Value US$42,718.02 | Price 71.20 | Shares 600
Planned sale 2 Dec 2013
Value US$168,548.64 | Price 70.23 | Shares 2,400
Planned sale 15 Nov 2013
Value US$38,817.00 | Price 77.63 | Shares 500
Planned sale 15 Nov 2013
Value US$76,725.60 | Price 75.89 | Shares 1,011
Planned sale 15 Nov 2013
Value US$36,639.30 | Price 74.93 | Shares 489
Planned sale 11 Nov 2013
Value US$144,057.06 | Price 80.03 | Shares 1,800
Planned sale 11 Nov 2013
Value US$355,299.75 | Price 79.34 | Shares 4,478
Planned sale 11 Nov 2013
Value US$48,755.41 | Price 78.38 | Shares 622
Planned sale 11 Nov 2013
Value US$15,228.00 | Price 76.14 | Shares 200
Planned sale 11 Nov 2013
Value US$14,886.00 | Price 74.43 | Shares 200
Planned sale 11 Nov 2013
Value US$14,602.50 | Price 73.01 | Shares 200
Planned sale 1 Nov 2013
Value US$8,434.00 | Price 84.34 | Shares 100
Planned sale 1 Nov 2013
Value US$167,180.00 | Price 83.59 | Shares 2,000
Planned sale 1 Nov 2013
Value US$115,866.80 | Price 82.76 | Shares 1,400
Planned sale 1 Nov 2013
Value US$33,597.20 | Price 83.99 | Shares 400
Planned sale 1 Nov 2013
Value US$128,994.10 | Price 83.22 | Shares 1,550
Planned sale 1 Nov 2013
Value US$24,684.00 | Price 82.28 | Shares 300
Planned sale 1 Nov 2013
Value US$414,050.50 | Price 82.81 | Shares 5,000
Planned sale 30 Oct 2013
Value US$119,016.48 | Price 99.18 | Shares 1,200
Planned sale 30 Oct 2013
Value US$28,770.00 | Price 95.90 | Shares 300
Planned sale 30 Oct 2013
Value US$18,850.00 | Price 94.25 | Shares 200
Planned sale 30 Oct 2013
Value US$37,200.00 | Price 93.00 | Shares 400
Planned sale 30 Oct 2013
Value US$64,421.00 | Price 92.03 | Shares 700
Planned sale 30 Oct 2013
Value US$228,031.00 | Price 91.21 | Shares 2,500
Planned sale 30 Oct 2013
Value US$242,592.03 | Price 89.85 | Shares 2,700
Planned sale 30 Oct 2013
Value US$338,243.32 | Price 89.01 | Shares 3,800
Planned sale 30 Oct 2013
Value US$528,618.68 | Price 87.83 | Shares 6,019
Planned sale 30 Oct 2013
Value US$870,752.00 | Price 87.08 | Shares 10,000
Planned sale 30 Oct 2013
Value US$198,859.84 | Price 85.94 | Shares 2,314
Planned sale 30 Oct 2013
Value US$600,689.35 | Price 85.00 | Shares 7,067
Planned sale 30 Oct 2013
Value US$235,620.84 | Price 84.15 | Shares 2,800
Planned sale 29 Oct 2013
Value US$237,690.00 | Price 95.00 | Shares 2,502
Planned sale 15 Oct 2013
Value US$80,709.00 | Price 80.71 | Shares 1,000
Planned sale 15 Oct 2013
Value US$79,950.00 | Price 79.95 | Shares 1,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2016-09-14 2016-09-13 B Purchase Broadfin Healthcare Master Fund Ltd Large shareholder
12,887 +18.8%
195.39
US$4,047,288 		12,887 +18.8% 195.39 US$4,047,288
2016-09-12 2016-09-12 B Purchase Broadfin Healthcare Master Fund Ltd Large shareholder
75,813 +36.0%
32.58
US$2,336,246 		75,813 +36.0% 32.58 US$2,336,246
2016-09-12 2016-09-12 B Purchase Broadfin Healthcare Master Fund Ltd Large shareholder
66,947 +39.2%
475.32
US$1,559,524 		66,947 +39.2% 475.32 US$1,559,524
2016-09-12 2016-09-09 B Purchase Broadfin Healthcare Master Fund Ltd Large shareholder
100,000 +2.5%
1.60
US$159,500 		100,000 +2.5% 1.60 US$159,500
2015-11-13 2015-11-11 B Purchase Broadfin Healthcare Master Fund Ltd Large shareholder
35,000 +0.9%
10.96
US$383,600 		35,000 +0.9% 10.96 US$383,600
2015-11-13 2015-11-11 B Purchase Broadfin Healthcare Master Fund Ltd Large shareholder
5,100 +0.1%
10.99
US$56,049 		5,100 +0.1% 10.99 US$56,049
2014-08-20 2014-08-19 B Purchase Fitzpatrick Mark J.

Chief Financial Officer

Officer
1,150 +13.8%
30.64
US$35,236 		1,150 +13.8% 30.64 US$35,236
2014-07-31 2014-07-31 B Purchase Beer Marc D

Chief Executive Officer

Executive Director
2,300 +3.0%
34.37
US$79,051 		2,300 +3.0% 34.37 US$79,051
2014-07-31 2014-07-31 B Purchase Beer Marc D

Chief Executive Officer

Executive Director
7,700 +11.1%
33.44
US$257,488 		7,700 +11.1% 33.44 US$257,488
2014-06-04 2014-06-03 B Purchase Beer Marc D

Chief Executive Officer

Executive Director
10,000 +16.8%
30.12
US$301,200 		10,000 +16.8% 30.12 US$301,200
2014-05-27 2014-05-27 B Purchase Beer Marc D

Chief Executive Officer

Executive Director
10,000 +20.2%
31.59
US$315,900 		10,000 +20.2% 31.59 US$315,900
2014-05-21 2014-05-20 B Purchase Beer Marc D

Chief Executive Officer

Executive Director
10,000 +30.3%
30.53
US$305,300 		10,000 +30.3% 30.53 US$305,300
2014-05-09 2014-05-08 B Purchase VANLENT ANNE Non-Executive Director
52 +1.3%
35.29
US$1,835 		52 +1.3% 35.29 US$1,835
2014-05-09 2014-05-08 B Purchase VANLENT ANNE Non-Executive Director
1,948 +97.4%
34.33
US$66,875 		1,948 +97.4% 34.33 US$66,875
2014-05-09 2014-05-08 B Purchase VANLENT ANNE Non-Executive Director
2,000 +inf%
33.20
US$66,400 		2,000 +inf% 33.20 US$66,400
2014-05-08 2014-05-08 B Purchase Beer Marc D

Chief Executive Officer

Executive Director
30,000 +1000.0%
35.31
US$1,059,300 		30,000 +1000.0% 35.31 US$1,059,300
2014-05-01 2014-04-30 PlS Planned sale Fraser Craig

Pres., US/Int. Comm. & Manuf.

Officer
1,171 -100.0%
43.90
US$51,407 		1,171 -100.0% 43.90 US$51,407
2014-05-01 2014-04-30 PlS Planned sale Fraser Craig

Pres., US/Int. Comm. & Manuf.

Officer
1,079 -48.0%
43.18
US$46,591 		1,079 -48.0% 43.18 US$46,591
2014-04-02 2014-03-31 PlS Planned sale Fraser Craig

Pres., US/Int. Comm. & Manuf.

Officer
100 -100.0%
47.20
US$4,720 		100 -100.0% 47.20 US$4,720
2014-04-02 2014-03-31 PlS Planned sale Fraser Craig

Pres., US/Int. Comm. & Manuf.

Officer
1,001 -90.9%
46.51
US$46,557 		1,001 -90.9% 46.51 US$46,557
2014-04-02 2014-03-31 PlS Planned sale Fraser Craig

Pres., US/Int. Comm. & Manuf.

Officer
1,149 -51.1%
45.84
US$52,670 		1,149 -51.1% 45.84 US$52,670
2014-03-18 2014-03-14 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
800 -100.0%
51.98
US$41,584 		800 -100.0% 51.98 US$41,584
2014-03-18 2014-03-14 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
900 -52.9%
51.31
US$46,179 		900 -52.9% 51.31 US$46,179
2014-03-18 2014-03-14 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
300 -15.0%
49.69
US$14,907 		300 -15.0% 49.69 US$14,907
2014-02-18 2014-02-14 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
500 -100.0%
64.52
US$32,260 		500 -100.0% 64.52 US$32,260
2014-02-18 2014-02-14 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
1,500 -75.0%
63.14
US$94,710 		1,500 -75.0% 63.14 US$94,710
2014-02-12 2014-02-11 PlS Planned sale Fraser Craig

Pres., US/Int. Comm. & Manuf.

Officer
2,250 -100.0%
67.00
US$150,750 		2,250 -100.0% 67.00 US$150,750
2014-02-12 2014-02-10 PlS Planned sale Fitzpatrick Mark J.

Chief Financial Officer

Officer
486 -7.7%
64.69
US$31,439 		486 -7.7% 64.69 US$31,439
2014-02-12 2014-02-10 PlS Planned sale Fitzpatrick Mark J.

Chief Financial Officer

Officer
900 -12.4%
63.72
US$57,348 		900 -12.4% 63.72 US$57,348
2014-02-12 2014-02-10 PlS Planned sale Fitzpatrick Mark J.

Chief Financial Officer

Officer
2,814 -28.0%
62.94
US$177,113 		2,814 -28.0% 62.94 US$177,113
2014-02-12 2014-02-10 PlS Planned sale Fitzpatrick Mark J.

Chief Financial Officer

Officer
3,300 -24.7%
61.71
US$203,643 		3,300 -24.7% 61.71 US$203,643
2014-01-21 2014-01-16 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
100 -100.0%
59.51
US$5,951 		100 -100.0% 59.51 US$5,951
2014-01-21 2014-01-16 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
1,900 -95.0%
58.59
US$111,318 		1,900 -95.0% 58.59 US$111,318
2014-01-06 2014-01-02 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
600 -100.0%
71.41
US$42,847 		600 -100.0% 71.41 US$42,847
2014-01-06 2014-01-02 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
400 -40.0%
70.22
US$28,087 		400 -40.0% 70.22 US$28,087
2014-01-06 2014-01-02 PlS Planned sale Fraser Craig

Pres., US/Int. Comm. & Manuf.

Officer
1,350 -100.0%
71.42
US$96,414 		1,350 -100.0% 71.42 US$96,414
2014-01-06 2014-01-02 PlS Planned sale Fraser Craig

Pres., US/Int. Comm. & Manuf.

Officer
900 -40.0%
70.65
US$63,584 		900 -40.0% 70.65 US$63,584
2013-12-17 2013-12-16 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
200 -100.0%
67.38
US$13,476 		200 -100.0% 67.38 US$13,476
2013-12-17 2013-12-16 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
1,800 -90.0%
66.23
US$119,211 		1,800 -90.0% 66.23 US$119,211
2013-12-04 2013-12-02 PlS Planned sale Fraser Craig

Pres., US/Int. Comm. & Manuf.

Officer
700 -100.0%
71.10
US$49,769 		700 -100.0% 71.10 US$49,769
2013-12-04 2013-12-02 PlS Planned sale Fraser Craig

Pres., US/Int. Comm. & Manuf.

Officer
1,550 -68.9%
70.10
US$108,654 		1,550 -68.9% 70.10 US$108,654
2013-12-04 2013-12-02 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
600 -100.0%
71.20
US$42,718 		600 -100.0% 71.20 US$42,718
2013-12-04 2013-12-02 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
2,400 -80.0%
70.23
US$168,549 		2,400 -80.0% 70.23 US$168,549
2013-11-19 2013-11-15 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
500 -100.0%
77.63
US$38,817 		500 -100.0% 77.63 US$38,817
2013-11-19 2013-11-15 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
1,011 -66.9%
75.89
US$76,726 		1,011 -66.9% 75.89 US$76,726
2013-11-19 2013-11-15 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
489 -24.4%
74.93
US$36,639 		489 -24.4% 74.93 US$36,639
2013-11-13 2013-11-11 PlS Planned sale Fitzpatrick Mark J.

Chief Financial Officer

Officer
1,800 -37.5%
80.03
US$144,057 		1,800 -37.5% 80.03 US$144,057
2013-11-13 2013-11-11 PlS Planned sale Fitzpatrick Mark J.

Chief Financial Officer

Officer
4,478 -48.3%
79.34
US$355,300 		4,478 -48.3% 79.34 US$355,300
2013-11-13 2013-11-11 PlS Planned sale Fitzpatrick Mark J.

Chief Financial Officer

Officer
622 -6.3%
78.38
US$48,755 		622 -6.3% 78.38 US$48,755
2013-11-13 2013-11-11 PlS Planned sale Fitzpatrick Mark J.

Chief Financial Officer

Officer
200 -2.0%
76.14
US$15,228 		200 -2.0% 76.14 US$15,228
2013-11-13 2013-11-11 PlS Planned sale Fitzpatrick Mark J.

Chief Financial Officer

Officer
200 -1.9%
74.43
US$14,886 		200 -1.9% 74.43 US$14,886
2013-11-13 2013-11-11 PlS Planned sale Fitzpatrick Mark J.

Chief Financial Officer

Officer
200 -1.9%
73.01
US$14,602 		200 -1.9% 73.01 US$14,602
2013-11-05 2013-11-01 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
100 -100.0%
84.34
US$8,434 		100 -100.0% 84.34 US$8,434
2013-11-05 2013-11-01 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
2,000 -95.2%
83.59
US$167,180 		2,000 -95.2% 83.59 US$167,180
2013-11-05 2013-11-01 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
1,400 -40.0%
82.76
US$115,867 		1,400 -40.0% 82.76 US$115,867
2013-11-05 2013-11-01 PlS Planned sale Fraser Craig

Pres., US/Int. Comm. & Manuf.

Officer
400 -100.0%
83.99
US$33,597 		400 -100.0% 83.99 US$33,597
2013-11-05 2013-11-01 PlS Planned sale Fraser Craig

Pres., US/Int. Comm. & Manuf.

Officer
1,550 -79.5%
83.22
US$128,994 		1,550 -79.5% 83.22 US$128,994
2013-11-05 2013-11-01 PlS Planned sale Fraser Craig

Pres., US/Int. Comm. & Manuf.

Officer
300 -13.3%
82.28
US$24,684 		300 -13.3% 82.28 US$24,684
2013-11-05 2013-11-01 PlS Planned sale Carter Martha J.

Chief Regulatory Officer & SVP

Officer
5,000 -76.9%
82.81
US$414,050 		5,000 -76.9% 82.81 US$414,050
2013-10-31 2013-10-30 PlS Planned sale Beer Marc D

Chief Executive Officer

Executive Director
1,200 -0.6%
99.18
US$119,016 		1,200 -0.6% 99.18 US$119,016
2013-10-31 2013-10-30 PlS Planned sale Beer Marc D

Chief Executive Officer

Executive Director
300 -0.2%
95.90
US$28,770 		300 -0.2% 95.90 US$28,770
2013-10-31 2013-10-30 PlS Planned sale Beer Marc D

Chief Executive Officer

Executive Director
200 -0.1%
94.25
US$18,850 		200 -0.1% 94.25 US$18,850
2013-10-31 2013-10-30 PlS Planned sale Beer Marc D

Chief Executive Officer

Executive Director
400 -0.2%
93.00
US$37,200 		400 -0.2% 93.00 US$37,200
2013-10-31 2013-10-30 PlS Planned sale Beer Marc D

Chief Executive Officer

Executive Director
700 -0.4%
92.03
US$64,421 		700 -0.4% 92.03 US$64,421
2013-10-31 2013-10-30 PlS Planned sale Beer Marc D

Chief Executive Officer

Executive Director
2,500 -1.2%
91.21
US$228,031 		2,500 -1.2% 91.21 US$228,031
2013-10-31 2013-10-30 PlS Planned sale Beer Marc D

Chief Executive Officer

Executive Director
2,700 -1.3%
89.85
US$242,592 		2,700 -1.3% 89.85 US$242,592
2013-10-31 2013-10-30 PlS Planned sale Beer Marc D

Chief Executive Officer

Executive Director
3,800 -1.8%
89.01
US$338,243 		3,800 -1.8% 89.01 US$338,243
2013-10-31 2013-10-30 PlS Planned sale Beer Marc D

Chief Executive Officer

Executive Director
6,019 -2.8%
87.83
US$528,619 		6,019 -2.8% 87.83 US$528,619
2013-10-31 2013-10-30 PlS Planned sale Beer Marc D

Chief Executive Officer

Executive Director
10,000 -4.5%
87.08
US$870,752 		10,000 -4.5% 87.08 US$870,752
2013-10-31 2013-10-30 PlS Planned sale Beer Marc D

Chief Executive Officer

Executive Director
2,314 -1.0%
85.94
US$198,860 		2,314 -1.0% 85.94 US$198,860
2013-10-31 2013-10-30 PlS Planned sale Beer Marc D

Chief Executive Officer

Executive Director
7,067 -3.0%
85.00
US$600,689 		7,067 -3.0% 85.00 US$600,689
2013-10-31 2013-10-30 PlS Planned sale Beer Marc D

Chief Executive Officer

Executive Director
2,800 -1.2%
84.15
US$235,621 		2,800 -1.2% 84.15 US$235,621
2013-10-31 2013-10-29 PlS Planned sale SMITH SANDFORD D Non-Executive Director
2,502 -100.0%
95.00
US$237,690 		2,502 -100.0% 95.00 US$237,690
2013-10-16 2013-10-15 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
1,000 -100.0%
80.71
US$80,709 		1,000 -100.0% 80.71 US$80,709
2013-10-16 2013-10-15 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
1,000 -50.0%
79.95
US$79,950 		1,000 -50.0% 79.95 US$79,950
Explore more

More insider trading research around Aegerion Pharmaceuticals Inc

More insider trades in United States
Insider trading in North America